"Lymphokines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity.
| Descriptor ID |
D008222
|
| MeSH Number(s) |
D12.644.276.374.480 D12.776.467.374.480 D23.529.374.480
|
| Concept/Terms |
Lymphokines- Lymphokines
- Lymphocyte Mediators
- Mediators, Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Lymphokines".
Below are MeSH descriptors whose meaning is more specific than "Lymphokines".
This graph shows the total number of publications written about "Lymphokines" by people in this website by year, and whether "Lymphokines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 3 | 4 |
| 2002 | 5 | 2 | 7 |
| 2003 | 3 | 2 | 5 |
| 2004 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphokines" by people in Profiles.
-
Exogenous IL-4 shuts off pro-inflammation in neutrophils while stimulating anti-inflammation in macrophages to induce neutrophil phagocytosis following myocardial infarction. J Mol Cell Cardiol. 2020 08; 145:112-121.
-
Identifying the molecular and cellular signature of cardiac dilation following myocardial infarction. Biochim Biophys Acta Mol Basis Dis. 2019 07 01; 1865(7):1845-1852.
-
Ubiquitin carboxyl terminal hydrolyase L1-suppressed autophagic degradation of p21WAF1/Cip1 as a novel feedback mechanism in the control of cardiac fibroblast proliferation. PLoS One. 2014; 9(4):e94658.
-
Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells. Cancer Biol Ther. 2004 Dec; 3(12):1304-12.
-
Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea. 2003 Jul; 22(5):473-7.
-
Structural elements of kallistatin required for inhibition of angiogenesis. Am J Physiol Cell Physiol. 2003 06; 284(6):C1604-13.
-
Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res. 2003 Mar 01; 63(5):906-11.
-
Chemoattraction of CD34+ progenitor cells and dendritic cells to the site of tumor excision as the first step of an immunotherapeutic approach to target residual tumor cells. J Immunother. 2003 Jan-Feb; 26(1):31-40.
-
Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest Ophthalmol Vis Sci. 2003 Jan; 44(1):137-44.
-
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Neoplasia. 2003 Jan-Feb; 5(1):83-92.